InsidersTradesSigma
Vitrolife AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Vitrolife AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Vitrolife AB has published 0 public disclosures. Market capitalisation: €11.5bn. Every trade is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Vitrolife AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 129.60.
Fundamental score
Ranked 20,411 of 28,257 companies
36.8
score / 100
Value32
Quality41
FCF yld3.4%
Earn yld-43%
EV/EBITDA·
ROE-47%
Gross mgn58%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Vitrolife AB
Vitrolife AB is a Swedish company focused on developing products and services for fertility and reproductive biology. It is listed on the Stockholm Stock Exchange (XSTO).